Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Mar;94(3):259-62.
doi: 10.1111/j.1349-7006.2003.tb01430.x.

Glypican-3 is overexpressed in human hepatocellular carcinoma

Young Kwan Sung  1 , Sun Young Hwang, Mi Kyung Park, Mohammad Farooq, In Sook Han, Han Ik Bae, Jung-Chul Kim, Moonkyu Kim
Affiliations

Glypican-3 is overexpressed in human hepatocellular carcinoma

Young Kwan Sung et al. Cancer Sci. 2003 Mar.

Abstract

To identify candidate genes that could be used as diagnostic and therapeutic targets for hepatocellular carcinoma (HCC), we searched for the genes that are overexpressed in HCC by combining representational difference analysis and microarray. Genes such as glypican-3 (GPC3), insulin-like growth factor 2, long-chain fatty-acid-coenzyme A ligase 4, farnesyl diphosphate synthase were frequently identified in our screening. Northern blot analysis with these four genes confirmed their overexpression in HCC. Among them we found that GPC3 transcript is upregulated in six out of seven cases of HCC. Immunoblot and immunohistochemical staining using polyclonal anti-GPC3 antibodies further confirmed that GPC3 protein is indeed increased in HCC tumor samples. We also found that GPC3 is secreted into culture media from cell lines derived from HCC. We conclude that GPC3 is a good molecular marker for HCC.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Filmus J, Shi W, Wong ZM, Wong MJ. Identification of a new membrane‐bound heparan sulphate proteoglycan. Biochem. J 1995; 311: 561–5. - PMC - PubMed
    1. Pilia G, Hughes‐Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D. Mutations in GPC3, a glypican gene, cause the Simpson‐Golabi‐Behmel overgrowth syndrome. Nat Genet 1996; 12: 241–7. - PubMed
    1. Cano‐Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J. Glypican‐3‐deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson‐Golabi‐Behmel syndrome. J Cell Biol 1999; 146: 255–64. - PMC - PubMed
    1. Paine‐Saunders S, Viviano BL, Zupicich J, Skarnes WC, Saunders S. Glypican‐3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Dev Biol 2000; 225: 179–87. - PubMed
    1. Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A. Overgrowth of a mouse model of the Simpson‐Golabi‐Behmel syndrome is independent of IGF signaling. Dev Biol 2002; 243: 185–206. - PubMed

Publication types